Possible prognostic markers in conjunctival dysplasia and squamous cell carcinoma

Japanese Journal of Ophthalmology

Volumn 42, Issue 4, 1998, Pages 256-261

  Aoki, Seiko ^a   Kubo, Eri ^a   Nakamura, Seigo ^a   Tsuzuki, Akiko ^a   Tsuzuki, Shosai ^a   Takahashi, Yukio ^a   Akagi, Yoshio ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Argyrophilic nucleolar organizer regions stain; Conjunctival dysplasia; p53 stain; Proliferating cell nuclear antigen stain; Squamous cell carinoma

Indexed keywords

CYCLINE; PROTEIN P53;

AGED; ARTICLE; CASE REPORT; CHROMOSOME NOR; CONJUNCTIVA TUMOR; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CONJUNCTIVA; CONJUNCTIVAL DISEASES; CONJUNCTIVAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; NUCLEOLUS ORGANIZER REGION; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032124264     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(98)00017-3     Document Type: Article

References (23)

1. 1. McGavic JS. Intraepithelial epithelioma of the cornea and conjunctiva (Bowen's disease). Am J Ophthalmol 1942;25: 167-76.
2. 2. Awan KJ. Intraepithelial epithelioma (Bowen's disease) of conjunctiva and chronic lymphocytic leukemia. Ann Ophthalmol 1978;10:781-3.
3. 3. Dixon RS, Mikhail GRC. Erythroplasia (Queyrat) of conjunctiva. J Am Acad Dermatol 1981;4:160-5.
4. 4. Pavelic ZP, Li Y-Q, Stambrook PJ, et al. Overexpression of p53 protein is common in premalignant head and neck lesions. Anticancer Res 1994;14:2259-66.
5. 5. Pizzarello LD, Jakobiec FA. Bowen's disease of the conjunctiva. A misnomer. In: Jakobiec FA, ed. Ocular and adnexal tumors. Birmingham: Aesculapius, 1978:553-71.
6. 6. McLean IW, Burnier MN, Zimmerman LE, et al. Tumor of the eye and ocular adnexa. In: Rosai J, Sobin LH, eds. Atlas of ocular pathology. Washington, DC: AFIP, 1994:49-95.
7. 7. Carroll JM, Kuwabata T. A classification of limbal epitheliomas. Arch Ophthalmol 1965;73:545-51.
8. 8. Fraunfelder FT, Wingfield D. Management of intraepithelial conjunctival tumors and squamous cell carcinomas. Am J Ophthalmol 1983;95:359-63.
9. 9. Nishida S. Two cases of dyskeratotic epithelial tumors of the bulbar conjunctiva at the limbus-intraepithelial epithelioma (Bowen) and dysplasia regarded as developmental stages in squamous cell carcinoma formation. Nihon Ganka Kiyo (Folia Ophthalmol Jpn) 1981;32:1578-87.
10. 10. Cain CT, Niemann TH, Argenyi ZB. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors. Am J Dermatopathol 1995;17:324-31.
11. 11. Coltrera MD, Zarbo RJ, Sakr WA, et al. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue. Am J Pathol 1992;141:817-25.
12. 12. Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162: 285-94.
13. 13. Kanitakis J, Hoyo E, Hermier C, et al. Nucleolar organizer region enumeration in keratoacanthomas and squamous cell carcinomas of the skin. Cancer 1992;69:2937-41.
14. 14. Kobayashi I, Matsuo K, Ozeki S, et al. The proliferative activity in oral epithelial dysplasia analyzed by proliferating cell nuclear antigen immunostaining and argyrophilic nucleolar organizer region staining. Hum Pathol 1995;26:907-13.
15. 15. Munck-Wikland E, Edström S, Jungmark E, et al. Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions. Int J Cancer 1994;56:95-9.
16. 16. Rüschoff J, Prasser C, Cortez T, et al. Diagnostic value of Ag-NOR staining in follicular cell neoplasms of the thyroid: comparison of evaluation methods and nucleolar features. Am J Surg Pathol 1993;17:1281-8.
17. 17. Sanders N, Bedotto C. Recurrent carcinoma in situ of the conjunctiva and cornea (Bowen's disease). Am J Ophthalmol 1972;74:688-93.
18. 18. Schmitz-Dräger BJ, van Roeyen CRC, Grimm M-O, et al. p53 accumulation in precursor lesions and early stages of bladder cancer. World J Urol 1994;12:79-83.
19. 19. Shindoh M, Chiba I, Yasuda M, et al. Detection of human papillomavirus DNA sequences in oral squamous cell carcinomas and their relation to p53 and proliferating cell nuclear antigen expression. Cancer 1995;76:1513-21.
20. 20. Tsuzuki H, Saitou Y, Imamura Y, et al. Early progression stage of malignancy as revealed by immunohistochemical demonstration of DNA instability; II otorhinolaryngeal border-line neoplastic lesions. Eur J Histochem 1994;38:291-302.
21. 21. Liebermann DA, Hoffman B, Steinman RA. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 1995;11:199-210.
22. 22. Sauter ER, Cleveland D, Trock B, et al. p53 is overexpressed in fifty percent of pre-invasive lesions of head and neck epithelium. Carcinogenesis 1994;15:2269-74.
23. 23. Crocker J. Nucleolar organizer regions. In: Underwood JCE, et al, eds. Pathology of the nucleus. London: Springer-Verlag, 1990:91-149.